简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:WASHINGTON (Reuters) – U.S. President Joe Biden will speak with infant formula retailers and manufacturers about supply issues on Thursday before the White House announces additional actions to address shortages, a White House official said.
div classBodysc17zpet90 cdBBJodivpWASHINGTON Reuters – U.S. President Joe Biden will speak with infant formula retailers and manufacturers about supply issues on Thursday before the White House announces additional actions to address shortages, a White House official said.p
pShortages developed after Abbott Laboratories in February recalled Similac and other baby formula made at its Michigan plant following complaints of bacterial infections in infants who consumed the products. pdivdivdiv classBodysc17zpet90 cdBBJodiv
pAbbott, the biggest supplier of milk formula in the United States, said on Wednesdasy it could restart production within two weeks of infant formula at the Michigan plant that has been tied to the shortages.p
pBiden will “receive an update on efforts to make infant formula supply more available to American families,” the White House official said. p
pThe official did not identify which company representatives would be at the meeting.p
pThe U.S. Food and Drug Administration has said it is working with manufacturers to alleviate supply issues and that several companies are at or over capacity.p
pA number of U.S. retailers, including Target Corp, CVS Health Corp and Walgreens Boots Alliance, have limited instore and online formula purchases.p
p
pp Reporting by Jeff Mason, Doina Chiacu and Susan Heavey Editing by Bill Berkrotp
divdivdiv classBodysc17zpet90 cdBBJodivdivdiv
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.